Mark J. Eisenberg, MD MPH FACC FAHA 5
Mark J. Eisenberg, MD MPH FACC FAHA 5
Mark J. Eisenberg, MD MPH FACC FAHA 5
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
5/1/2012<br />
39<br />
<strong>Mark</strong> J. <strong>Eisenberg</strong>, <strong>MD</strong> <strong>MPH</strong> <strong>FACC</strong> <strong>FAHA</strong><br />
33. *Bhatia SR, <strong>Eisenberg</strong> MJ. Medication dosages following percutaneous transluminal<br />
coronary angioplasty: Results from the ROSETTA Registry. J Am Coll Cardiol 2001;<br />
(Suppl A) 37:299A.<br />
34. *Deligonul U, <strong>Eisenberg</strong> MJ et al. Utility of routine functional testing after PTCA in<br />
patients with diabetes mellitus. J Am Coll Cardiol 2001; (Suppl A) 37:58A.<br />
35. Beck C, Joseph L, <strong>Eisenberg</strong> MJ et al. Predictors of quality of life 6 months and 1 year<br />
after acute myocardial infarction. J Am Coll Cardiol 2001; (Suppl A) 37:491A.<br />
36. Pilote L, Huynh T, <strong>Eisenberg</strong> MJ et al. A prospective cohort study of quality of life after<br />
acute myocardial infarction at sites with and without coronary angiography. J Am Coll<br />
Cardiol 2001; (Suppl A) 37:491A.<br />
37. Pilote L, Joseph L, <strong>Eisenberg</strong> MJ et al. Universal health insurance coverage does not<br />
eliminate inequities in access to cardiac procedures after acute myocardial infarction. J<br />
Am Coll Cardiol 2001; (Suppl A) 37:497A.<br />
38. <strong>Eisenberg</strong> MJ, Pilote L, Blankenship J et al. Aggressive diagnosis of restenosis: results<br />
from the ADORE Trial. American College of Cardiology Meeting 2001 (Late-Breaking<br />
Clinical Trials Session) 38:599.<br />
39. *Puri R, <strong>Eisenberg</strong> MJ, Sedlis S, Arbor A, Azrin M, Siegel R, Smilovitch M, Pilote L,<br />
Azoulay A. Routine functional testing following single and multi-lesion percutaneous<br />
coronary interventions: results from the ADORE Trial. Circulation 2001; 104:II-734.<br />
40. Simpson EA, Beck CA, Richard H, Rodrigues EJ, Merrett P, Pilote L, <strong>Eisenberg</strong> MJ.<br />
"Evidence-based" drug prescriptions post-acute myocardial infarction: Prescription<br />
combinations, compliance and persistence. Circulation 2001; 104:II-838.<br />
41. Mak KH, Puri R, <strong>Eisenberg</strong> MJ. Lack of benefit from routine functional testing among<br />
patients undergoing coronary stenting: insights from the ADORE Trial. J Am Coll<br />
Cardiol 2002; (Suppl A) 39:24A.<br />
42. *Cugno S, <strong>Eisenberg</strong> MJ et al. Impact of percutaneous coronary intervention on<br />
functional status: results from the ADORE Trial. J Am Coll Cardiol 2002; (Suppl A)<br />
39:179A.<br />
43. *Brox A, Azoulay A, Filion KB, <strong>Eisenberg</strong> MJ. Cost of abdominal aortic aneurysm<br />
repair in Canada and the United States. J Am Coll Cardiol 2002; (Suppl A) 39:439A.<br />
44. *Rudski LG, Dharsi K, Paterson DI, Dascal A, <strong>Eisenberg</strong> MJ. Patterns of treatment for<br />
native valve streptococus viridans endocarditis among cardiologists versus infectious<br />
disease specialists. J Am Coll Cardiol 2002; (Suppl A) 39:455A.<br />
45. *Azoulay A, <strong>Eisenberg</strong> MJ. The use of transition cost accounting system to compare<br />
costs of treatment between Canada and the United States: Methodological issues based on<br />
the case of acute myocardial infarction. Eclipsys User Network and Can TSI Conf 2001.